Clene, Inc. (CLNN)
4.05
-0.23
(-5.37%)
USD |
NASDAQ |
Sep 01, 15:42
Clene Cash from Operations (TTM) : -15.96M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.96M |
| March 31, 2026 | -18.11M |
| December 31, 2025 | -18.59M |
| September 30, 2025 | -18.63M |
| June 30, 2025 | -17.70M |
| March 31, 2025 | -19.33M |
| December 31, 2024 | -21.40M |
| September 30, 2024 | -23.70M |
| June 30, 2024 | -27.43M |
| March 31, 2024 | -28.09M |
| December 31, 2023 | -30.23M |
| September 30, 2023 | -30.85M |
| June 30, 2023 | -32.54M |
| March 31, 2023 | -35.19M |
| December 31, 2022 | -39.05M |
| September 30, 2022 | -40.79M |
| Date | Value |
|---|---|
| June 30, 2022 | -39.60M |
| March 31, 2022 | -38.47M |
| December 31, 2021 | -34.55M |
| September 30, 2021 | -43.11M |
| June 30, 2021 | -43.57M |
| March 31, 2021 | -37.19M |
| December 31, 2020 | -31.28M |
| September 30, 2020 | -13.27M |
| June 30, 2020 | -5.737M |
| March 31, 2020 | -3.754M |
| December 31, 2019 | -0.5977M |
| September 30, 2019 | -0.4803M |
| June 30, 2019 | -0.4237M |
| March 31, 2019 | -0.2883M |
| December 31, 2018 | -0.2056M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| NovelStem International Corp. | -0.2295M |
| Brainstorm Cell Therapeutics, Inc. | -4.057M |
| Summit Therapeutics, Inc. | -457.02M |
| Kezar Life Sciences, Inc. | -42.03M |
| Protara Therapeutics, Inc. | -66.13M |